Treatment efficacy for depression (short term: 8–9 weeks) · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).
1 finding from 1 review
Social adjustment and functioning (medium term: 12 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Improvement in anxiety symptoms (medium term: 12 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Acceptability · depression in adults with non‐communicable diseases
Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).
1 finding from 1 review
Improvement in depression symptoms (short term: 5–6 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Quality of life (short term: 6 months) · depression in adults with non‐communicable diseases
1 finding from 1 review
Intervention not reported
Leg pain ‒short‐term · lumbosacral radicular pain
The intervention showed no clear difference in leg pain ‒short‐term (moderate certainty).
1 finding from 1 review
Intervention not reported
Disability ‒short‐term (> 2 weeks but ≤ 3 months) Disability reported using multiple scales (RMDQ and ODI). Disability scores were converted to a common 0 to 100 scale. Higher scores indicate greater disability. · lumbosacral radicular pain
The intervention showed no clear difference in disability ‒short‐term (> 2 weeks but ≤ 3 months) Disability… (moderate certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events** ‒short‐term (> 2 weeks but ≤ 3 months) Minor adverse events provided as the proportion of patients reporting any untoward medical occurrence after an epidural injection without hospitalisations. · lumbosacral radicular pain
It is very uncertain whether the intervention changes minor adverse events** ‒short‐term (> 2 weeks but ≤ 3 months) Minor… (very low certainty).
1 finding from 1 review
Intervention not reported
Major adverse events** ‒short‐term (> 2 weeks but ≤ 3 months) Major adverse events provided as the proportion of patients reporting any untoward medical occurrence after an epidural injection with hospitalizations. · lumbosacral radicular pain
1 finding from 1 review
Gingivitis · Children and adults with mixed levels of ID; setting home, residential, day care, school, mixed or not specified
1 finding from 1 review
Electric vs manual toothbrush. Assorted gingival indices scale 0-4, 2-4 weeks; 252 participants (4 RCTs); Low. Four studies showed no significant differences for gingival inflammation short term; data could not be…
4 studies · 252 participants
Low
Gingivitis · Children aged 7 to 13 years with Down syndrome (mild to moderate ID); setting residential
1 finding from 1 review
Toothpaste with a plaque-disclosing agent vs conventional toothpaste, children with Down syndrome. Ainamo & Bay Gingival Bleeding Index, mean 10 days; percent mean difference 18 (intervention) vs 8 (control), P<0.001…
1 study · 40 participants
Very low
Plaque · Children aged 7 to 13 years with Down syndrome (mild to moderate ID); setting residential
1 finding from 1 review
Simplified Green & Vermillion Oral Hygiene Index (plaque), mean 10 days; percent mean difference 65 (intervention) vs 15 (control), P<0.0001 favouring the disclosing-agent toothpaste; 40 participants (SoF states 80,…
1 study · 40 participants
Very low
Plaque · Children and adults with mild to profound ID; setting residential or school
It is very uncertain whether oral hygiene training (toothbrushing routine) of people with ID changes plaque (short term) compared with no oral hygiene training of people with ID (very low certainty).
1 finding from 1 review
General well‐being · adults and children with CF
1 finding from 1 review
Well being: Short Form ‐36 · adults and children with cystic fibrosis
1 finding from 1 review
Health‐related quality of life (HRQoL) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (HRQoL) · people with ESKD
Cognitive‐behavioural therapy probably leads to higher health‐related quality of life Investigators measured health‐related… compared with usual care (moderate certainty).
1 finding from 1 review
Quality of life Short‐Form 36 health survey (SF‐36) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Short‐term serious adverse events · people with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review